feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Supplement Recalled: Undeclared ED Drug Found!

Supplement Recalled: Undeclared ED Drug Found!

4 Feb

Summary

  • Energy support supplement recalled for undeclared erectile dysfunction medication.
  • Contaminated product sold nationwide via Amazon and company website.
  • Tadalafil poses risks, especially when combined with heart medications.
Supplement Recalled: Undeclared ED Drug Found!

An 'energy support' supplement, Ashfiat Alharamain Energy Support, is being recalled by Virginia-based Akkarco LLC because it contains undeclared Tadalafil. This medication is used to treat erectile dysfunction and can only be obtained under medical supervision. The FDA emphasizes that products containing Tadalafil cannot be marketed as dietary supplements, as supplements are not regulated in the US.

The recall specifically targets the product in a glass bottle with an orange label, identified by UPC 1234561870003, batch number ENCOT24, and an October 2028 expiration date. This contaminated supplement was available for purchase nationwide through Amazon and the company's website.

Consumers using Tadalafil without a prescription and supervision may face significant health issues, including heart and blood pressure problems, dizziness, and headaches. The risks are amplified for individuals using nitroglycerin or similar medications for chest pain, as combining them with Tadalafil can lead to a critical drop in blood pressure, potentially causing fainting, heart attack, or stroke.

Customers are urged to cease using the product immediately and dispose of it or return it for a refund. The recall was initiated after FDA testing confirmed the presence of Tadalafil in the Akkarco product. A similar recall involving Tadalafil and Sildenafil occurred in December for MR.7 SUPER 700000 capsules.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
It is being recalled because it was found to be contaminated with Tadalafil, an undeclared medication used to treat erectile dysfunction.
Consuming Tadalafil without proper medical supervision can lead to heart and blood pressure problems, dizziness, and headaches. It is especially dangerous if combined with heart medications like nitroglycerin.
The recalled Ashfiat Alharamain Energy Support was sold nationwide through Amazon and the company's website.

Read more news on

Healthside-arrowAmazon Leoside-arrow
•
trending

Nvidia share price drops sharply

trending

Anthropic AI triggers IT selloff

trending

India U19 World Cup final

trending

UGC NET December Result Soon

trending

GTA 6 release confirmed

trending

Raducanu recovers, wins quarter-final

trending

Nasdaq considers 'fast entry' rule

trending

Ronaldo trains with Al Nassr

trending

T20 World Cup 2026 details

You may also like

Regeneron's Drug: Weight Loss Plus Heart Health?

31 Jan • 39 reads

article image

AstraZeneca Bets Big on New Obesity Drug Race

30 Jan • 30 reads

article image

Knock-off Weight Drugs: Deadly Risks Exposed

30 Jan • 59 reads

article image

FDA Clears Wegovy, Zepbound: No Suicidal Thoughts Link

13 Jan • 147 reads

article image

Viking CEO: Weight-Loss Deals More Intense Than Seen

13 Jan • 153 reads

article image